EP0915904A4 - GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR - Google Patents

GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR

Info

Publication number
EP0915904A4
EP0915904A4 EP97926403A EP97926403A EP0915904A4 EP 0915904 A4 EP0915904 A4 EP 0915904A4 EP 97926403 A EP97926403 A EP 97926403A EP 97926403 A EP97926403 A EP 97926403A EP 0915904 A4 EP0915904 A4 EP 0915904A4
Authority
EP
European Patent Office
Prior art keywords
mammalian
midleg
acts
tumor suppressor
scm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97926403A
Other languages
German (de)
English (en)
Other versions
EP0915904A1 (fr
Inventor
Filippo Randazzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of EP0915904A1 publication Critical patent/EP0915904A1/fr
Publication of EP0915904A4 publication Critical patent/EP0915904A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4745—Cancer-associated SCM-recognition factor, CRISPP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP97926403A 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR Withdrawn EP0915904A4 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US1687696P 1996-05-06 1996-05-06
US16876P 1996-05-06
US1729496P 1996-05-13 1996-05-13
US17294P 1996-05-13
US2045096P 1996-06-18 1996-06-18
US20450P 1996-06-18
US3299496P 1996-12-16 1996-12-16
US32994P 1996-12-16
US3509097P 1997-01-14 1997-01-14
US35090P 1997-01-14
PCT/US1997/007575 WO1997042211A1 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN Scm A EFFET SUPPRESSEUR DE TUMEUR

Publications (2)

Publication Number Publication Date
EP0915904A1 EP0915904A1 (fr) 1999-05-19
EP0915904A4 true EP0915904A4 (fr) 2001-05-02

Family

ID=27533705

Family Applications (2)

Application Number Title Priority Date Filing Date
EP97926403A Withdrawn EP0915904A4 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR
EP97924583A Withdrawn EP0960120A4 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET ONCOGENE

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP97924583A Withdrawn EP0960120A4 (fr) 1996-05-06 1997-05-06 GENE MAMMALIEN (Scm) A EFFET ONCOGENE

Country Status (4)

Country Link
EP (2) EP0915904A4 (fr)
JP (2) JP2000513212A (fr)
AU (2) AU3117597A (fr)
WO (2) WO1997042211A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0915904A4 (fr) * 1996-05-06 2001-05-02 Chiron Corp GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR
WO1999050278A1 (fr) * 1998-03-31 1999-10-07 Genzyme Corporation Compositions et methodes d'identification de cellules de tumeur du poumon
US6203989B1 (en) 1998-09-30 2001-03-20 Affymetrix, Inc. Methods and compositions for amplifying detectable signals in specific binding assays

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016178A2 (fr) * 1992-02-12 1993-08-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences caracteristiques du produit de transcription des genes humains
WO1997042218A1 (fr) * 1996-05-06 1997-11-13 Chiron Corporation GENE MAMMALIEN Scm A EFFET ONCOGENE

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016178A2 (fr) * 1992-02-12 1993-08-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Sequences caracteristiques du produit de transcription des genes humains
WO1997042218A1 (fr) * 1996-05-06 1997-11-13 Chiron Corporation GENE MAMMALIEN Scm A EFFET ONCOGENE

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BORNEMANN DOUGLAS ET AL: "The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein.", DEVELOPMENT (CAMBRIDGE), vol. 122, no. 5, 1996, pages 1621 - 1630, XP002161672, ISSN: 0950-1991 *
NOMURA M ET AL: "ISOLATION AND CHARACTERIZATION OF REINOIC ACID-INDUCIBLE CDNA CLONES IN F9 CELLS: ONE OF THE EARLY INDUCIBLE CLONES ENCODES A NOVEL PROTEIN SHARING SEVERAL HIGHLY HOMOLOGOUS REGIONS WITH A DROSOPHILA POLYHOMEOTIC PROTEIN", DIFFERENTIATION,DE,SPRINGER VERLAG, vol. 57, no. 1, 1 June 1994 (1994-06-01), pages 39 - 50, XP002046787, ISSN: 0301-4681 *
See also references of WO9742211A1 *

Also Published As

Publication number Publication date
JP2000513212A (ja) 2000-10-10
EP0960120A1 (fr) 1999-12-01
AU3117597A (en) 1997-11-26
WO1997042211A1 (fr) 1997-11-13
WO1997042218A1 (fr) 1997-11-13
AU2996797A (en) 1997-11-26
EP0960120A4 (fr) 2001-05-02
EP0915904A1 (fr) 1999-05-19
JP2000510693A (ja) 2000-08-22

Similar Documents

Publication Publication Date Title
AP9801334A0 (en) Ther peuti comb natio
AP9801356A0 (en) Prostaglandin agonists
AU1641497A (en) Long wearing lipstick
EP0904772A4 (fr) Agent ameliorant le teint de la peau
IL131451A0 (en) Orotracheal intubatin guide
EP0915904A4 (fr) GENE MAMMALIEN (Scm) A EFFET SUPPRESSEUR DE TUMEUR
IL117498A (en) Valise
GB9626130D0 (en) Improved doctor assembly
EP0465022A3 (en) Pistons
GB9608039D0 (en) Plunger assembly
AU124926S (en) Lipstick case
EP0409632A3 (en) Piston assembly
EP0922053A4 (fr) GENE MAMMALIEN Asx AGISSANT COMME SUPPRESSEUR TUMORAL
EP1032591A4 (fr) NOUVEAU pth
GB9707922D0 (en) Stabilized isothioazolone solution
GB9607000D0 (en) Handbag assembly
GB9418821D0 (en) Ovulation predictor
AU7070198A (en) Hyperemia comb
KR100216789B1 (en) Piston
TW364561U (en) Improvement on structure of piston
AU2629899A (en) Electrolysis needle assembly for epilation
HUP9601960A3 (en) Piston with inclined slot
GB9713945D0 (en) Improvements relating to tissue transplantation
TW361550U (en) Improved structure for the piston
GB9715730D0 (en) Free piston emgine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981127

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 15/12 A, 7C 12N 15/63 B, 7C 07K 14/47 B, 7C 07K 16/18 B, 7A 61K 31/70 B, 7A 61K 39/00 B, 7G 01N 33/53 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010319

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021203